Literature DB >> 12032519

Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage.

Robert Mittendorf1, James Dambrosia, Olaf Dammann, Peter G Pryde, Kwang-Sun Lee, Tamar E Ben-Ami, David Yousefzadeh.   

Abstract

OBJECTIVES: To determine whether magnesium sulfate (MgSO(4)) exposure is associated with a reduced risk for neonatal intraventricular hemorrhage (IVH). STUDY
DESIGN: In a randomized, controlled trial, women in preterm labor were randomly assigned to receive MgSO(4), "other" tocolytic, or saline control. At delivery, we collected maternal antecubital and umbilical cord blood for determination of serum ionized magnesium levels. Neonatal IVH was diagnosed by cranial ultrasonogram.
RESULTS: Among 144 infants, 24 were diagnosed with IVH. Using crude intention-to-treat analysis, we found that 18% (13/74) of survivors exposed after birth to MgSO(4) had IVH compared with 16% (11/70) of babies who were not exposed. Infants who had IVH were more likely to have been delivered by mothers with higher serum ionized magnesium (Mg) levels (0.75 vs 0.56 mmol/L) (P =.01). Using multivariable logistic regression, we confirmed that higher Mg levels are a significant predictor of neonatal IVH (adjusted odds ratio, 15.8; 95% CI, 1.4-175.0) even when adjusted for birth weight, gestational age, antenatal hemorrhage, and neonatal glucocorticoid exposure.
CONCLUSIONS: In mothers with preterm labor, our data indicate that antenatal MgSO(4) exposure may be associated with an increased risk for IVH among their newborns.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032519     DOI: 10.1067/mpd.2002.123283

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

Review 1.  Pharmacokinetics of tocolytic agents.

Authors:  Vassilis Tsatsaris; Dominique Cabrol; Bruno Carbonne
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.

Authors:  D Narasimhulu; A Brown; N M Egbert; M Rojas; S Haberman; A Bhutada; H Minkoff; S Rastogi
Journal:  J Perinatol       Date:  2017-10-05       Impact factor: 2.521

3.  Magnesium sulfate tocolysis and intraventricular hemorrhage in very preterm infants.

Authors:  Anna Petrova; Rajeev Mehta
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

Review 4.  Tocolytics for delaying preterm birth: a network meta-analysis (0924).

Authors:  Amie Wilson; Victoria A Hodgetts-Morton; Ella J Marson; Alexandra D Markland; Eva Larkai; Argyro Papadopoulou; Arri Coomarasamy; Aurelio Tobias; Doris Chou; Olufemi T Oladapo; Malcolm J Price; Katie Morris; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2022-08-10

Review 5.  Perinatal management: What has been learned through the network?

Authors:  Sanjay Chawla; Elizabeth E Foglia; Vishal Kapadia; Myra H Wyckoff
Journal:  Semin Perinatol       Date:  2016-08-01       Impact factor: 3.300

6.  Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.

Authors:  Amanda L Horton; Yinglei Lai; Dwight J Rouse; Catherine Y Spong; Kenneth J Leveno; Michael W Varner; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Mary J O'Sullivan; Gary D V Hankins; Steve N Caritis
Journal:  Am J Perinatol       Date:  2014-09-21       Impact factor: 1.862

7.  Maternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations.

Authors:  Catherine M T Sherwin; Alfred Balch; Sarah C Campbell; Jeunesse Fredrickson; Erin A S Clark; Michael Varner; Chris Stockmann; E Kent Korgenski; Joshua L Bonkowsky; Michael G Spigarelli
Journal:  Basic Clin Pharmacol Toxicol       Date:  2013-12-11       Impact factor: 4.080

8.  Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants.

Authors:  Lilia C De Jesus; Beena G Sood; Seetha Shankaran; Douglas Kendrick; Abhik Das; Edward F Bell; Barbara J Stoll; Abbot R Laptook; Michele C Walsh; Waldemar A Carlo; Pablo J Sanchez; Krisa P Van Meurs; Rebecca Bara; Ellen C Hale; Nancy S Newman; M Bethany Ball; Rosemary D Higgins
Journal:  Am J Obstet Gynecol       Date:  2014-07-18       Impact factor: 8.661

9.  Experimental and clinical evidence of differential effects of magnesium sulfate on neuroprotection and angiogenesis in the fetal brain.

Authors:  Matthieu Lecuyer; Marina Rubio; Clément Chollat; Maryline Lecointre; Sylvie Jégou; Philippe Leroux; Carine Cleren; Isabelle Leroux-Nicollet; Loic Marpeau; Denis Vivien; Stéphane Marret; Bruno J Gonzalez
Journal:  Pharmacol Res Perspect       Date:  2017-08

10.  The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity.

Authors:  Joao Guilherme B Alves; Carla Adriane Fonseca Leal de Araújo; Isabelle E A Pontes; Angélica C Guimarães; Joel G Ray
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-08       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.